Cereno Scientific AB (OSTO:CRNO B) Dividends per Share : kr0.00 (TTM As of Mar. 2025)

View and export this data going back to 2016. Start your Free Trial

What is Cereno Scientific AB Dividends per Share?

Cereno Scientific AB's dividends per share for the three months ended in Mar. 2025 was kr0.00. Its dividends per share for the trailing twelve months (TTM) ended in Mar. 2025 was kr0.00. Its Dividend Payout Ratio for the three months ended in Mar. 2025 was 0.00. As of today, Cereno Scientific AB's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Cereno Scientific AB Dividends per Share Historical Data

The historical data trend for Cereno Scientific AB's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cereno Scientific AB Dividends per Share Chart

Cereno Scientific AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dividends per Share

Get a 7-Day Free Trial

Cereno Scientific AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Dividends per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Cereno Scientific AB's Dividends per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Cereno Scientific AB's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cereno Scientific AB's Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cereno Scientific AB's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Cereno Scientific AB's Dividend Yield % falls into.

Save Embed

;

Save Embed

;

Cereno Scientific AB Dividends per Share Calculation

Dividends paid to per common share.

Cereno Scientific AB (OSTO:CRNO B) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Cereno Scientific AB's Dividend Payout Ratio for the quarter that ended in Mar. 2025 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2025 )	/	EPS without NRI (Q: Mar. 2025 )
	=	0	/	-0.09
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Cereno Scientific AB Dividends per Share Related Terms

Thank you for viewing the detailed overview of Cereno Scientific AB's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Cereno Scientific AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cereno Scientific AB (OSTO:CRNO B) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

4A1:Germany

Address

BioVentureHub, Pepparedsleden 1, Molndal, SWE, 431 83

Website

https://www.cerenoscientific.se

Cereno Scientific AB is developing a pipeline of preventive therapeutics to treat cardiovascular and rare diseases by epigenetic modulation through histone deacetylase inhibition (HDACi). The company's lead program, CS1, is a phase two dual-acting antithrombotic drug aimed at venous thrombosis and stroke prevention for atrial fibrillation. Cereno Scientificalso evaluates the potential of epigenetic modulation for rare diseases related to pulmonary fibrosis, thrombosis, inflammation, and high blood pressure in the pulmonary circulation system.

Cereno Scientific AB Headlines

No Headlines